Co-Authors
This is a "connection" page, showing publications co-authored by Shiyue Li and Ling Sang.
Connection Strength
1.654
-
Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective study. Ann Palliat Med. 2021 Aug; 10(8):8557-8570.
Score: 0.240
-
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU. Exp Hematol Oncol. 2021 Feb 01; 10(1):6.
Score: 0.232
-
The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med. 2020 Nov 09; 20(1):290.
Score: 0.228
-
Clinical Features of Coronavirus Disease 2019 Patients With Mechanical Ventilation: A Nationwide Study in China. Crit Care Med. 2020 09; 48(9):e809-e812.
Score: 0.225
-
Serum amyloid A is a predictor for prognosis of COVID-19. Respirology. 2020 07; 25(7):764-765.
Score: 0.220
-
Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med. 2021 Jun; 9(11):941.
Score: 0.059
-
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China. Clin Respir J. 2021 Aug; 15(8):915-924.
Score: 0.059
-
Addendum: Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2021 02 01; 12(1):826.
Score: 0.058
-
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 08 01; 180(8):1081-1089.
Score: 0.056
-
Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2020 07 15; 11(1):3543.
Score: 0.056
-
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
Score: 0.055
-
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
Score: 0.055
-
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
Score: 0.055
-
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 07; 158(1):97-105.
Score: 0.055